“…The majority (54%) of the HIV-infected children were admitted to the Russia AIDS Centre with bacterial and fungal infections. The high prevalence of OPC in about half of them contributed to the decision to use azole drugs in their treatment (13). Fluconazole has been successful in treating OPC and esophageal candidiasis in HIV-infected patients (14,20,23), but its long-term use raises the possibility of the acquisition of resistance by the yeast Candida albicans (7,12,17,25) and the emergence of other Candida species, such as C. krusei and C. glabrata, with innately reduced susceptibilities to fluconazole (5,27).…”